Primary glomerular diseases and long‐term adverse health outcomes: A nationwide cohort study
Journal of Internal Medicine · 2025
DOI: 10.1111/joim.20024 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Internal Medicine, 2025. Verfasst von Anne-Laure Faucon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Hospitalization, Glomerulosclerosis, Focal Segmental. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS, Swedish Research Council, Region Stockholm (Center of Innovative MEDicine (CIMED), and ALF Medicine).
Abstract (Originalsprache)
Background
Although glomerular diseases are the third most frequent cause of end‐stage kidney disease worldwide, little is known about their long‐term outcomes.
Methods
In patients with chronic kidney disease (CKD) stage 3–5 enrolled in the Swedish Renal Registry, we compared risks of hospitalization, kidney replacement therapy (KRT), major cardiovascular events (MACE), and death of the four most frequent primary glomerular diseases (IgA nephropathy [IgAN], focal segmental glomerulosclerosis [FSGS], minimal change disease [MCD], and membranous nephropathy [MN]), and patients with CKD due to the most common non‐communicable diseases (control‐CKD).
Results
We identified 2396 patients with glomerular disease (97% biopsy‐proven, 69% men, 57 years, eGFR 29 mL/min/1.73 m 2 , uACR 88 mg/mmol, 1524 with IgAN, 398 FSGS, 94 MCD, and 380 MN) and 37,697 controls (64% men, 74 years, eGFR 25 mL/min/1.73 m 2 , uACR 23 mg/mmol), mainly with diabetic nephropathy and nephroangiosclerosis. The median follow‐up was 6.3 (3.3; 9.9) years. Compared with control‐CKD, patients with primary glomerular diseases generally had a lower risk of hospitalization, MACE (adjusted hazard ratios [HRs] ranging from 0.44 to 0.88 depending on the etiology) and death (HRs ranging 0.45–0.76). Patients with IgAN and FSGS had a faster eGFR decline and a higher rate of KRT (HRs 1.26 [95%CI: 1.15–1.37] and 1.34 [1.15–1.57], respectively). Conversely, patients with MN and MCD had a lower KRT rate and slower eGFR decline.
Conclusion
Despite having a lower relative risk of hospitalization, cardiovascular events and mortality, patients with IgAN and FSGS are at higher risk of CKD progression than the most common etiologies of CKD, emphasizing the need for more stringent treatment strategies in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Department of Clinical Epidemiology, INSERM UMR 1018, Centre for Epidemiology and Population Health, Paris-Saclay University, Paris, France.
- Department of Biostatistics, University of Milano-Bicocca, Milan, Italy.
- Department of Nephrology, Karolinska University Hospital, Stockholm, Sweden.
- Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
- Department of Medical Specialist Care, Nephrology Clinic, Danderyd University Hospital, Stockholm, Sweden.
ORCID-Profile: Anne-Laure Faucon, Julia Wijkström, Juan-Jesús Carrero
Förderung
- NIDDK NIH HHS
- Swedish Research Council
- Region Stockholm (Center of Innovative MEDicine (CIMED), and ALF Medicine)
- CSL Vifor
- Swedish Heart and Lung Foundation
- US National Institute of Health
- Vetenskapsrådet
Zitieren
APA
Faucon, A. L., Lando, S., Chrysostomou, C., Wijkström, J., Lundberg, S., Bellocco, R., Segelmark, M., Evans, M., & Carrero, J. J. (2025). Primary glomerular diseases and long‐term adverse health outcomes: A nationwide cohort study. Journal of Internal Medicine. https://doi.org/10.1111/joim.20024
Vancouver
Faucon AL, Lando S, Chrysostomou C, Wijkström J, Lundberg S, Bellocco R, et al. Primary glomerular diseases and long‐term adverse health outcomes: A nationwide cohort study. Journal of Internal Medicine. 2025. doi:10.1111/joim.20024
BibTeX
@article{Faucon2025,
author = {Faucon, Anne-Laure and Lando, Stefania and Chrysostomou, Charikleia and Wijkström, Julia and Lundberg, Sigrid and Bellocco, Rino and Segelmark, Mårten and Evans, Marie and Carrero, Juan-Jesús},
title = {Primary glomerular diseases and long‐term adverse health outcomes: A nationwide cohort study},
journal = {Journal of Internal Medicine},
year = {2025},
doi = {10.1111/joim.20024}
}
EUVIMED